Muscle and Bone Defects in Metastatic Disease

Area of Science:

• Oncology
• Metabolism
• Biochemistry

Background:

• Metastatic cancer frequently leads to skeletal muscle defects, including bone destruction and muscle atrophy.
• Secreted molecules and extracellular vesicles play roles in cancer progression, bone loss, and muscle wasting.
• Altered muscle microenvironment, hepatic, and mitochondrial metabolism contribute to cancer-induced muscle loss.

Purpose of the Study:

• To review recently identified mechanisms of metastasis-induced bone resorption and cancer cachexia.
• To discuss novel in vitro and animal models for studying bone metastases and cachexia.
• To highlight potential new drug candidates for treating these conditions.

Main Methods:

• Literature review of recent studies on cancer metastasis, bone resorption, and cachexia.
• Analysis of molecular pathways and cellular mechanisms involved in bone-muscle crosstalk.
• Evaluation of emerging therapeutic strategies and drug candidates.

Main Results:

• Identification of key secreted molecules and extracellular vesicles driving bone destruction and muscle atrophy.
• Elucidation of metabolic dysfunctions in the muscle microenvironment contributing to muscle loss.
• Highlighting the link between bone health preservation and muscle mass maintenance.

Conclusions:

• Understanding bone-muscle crosstalk in metastatic disease is crucial for developing novel anticancer therapeutics.
• Targeting molecular pathways involved in metastasis-induced bone resorption and cachexia may improve patient outcomes.
• Preserving bone health is a potential strategy to maintain muscle mass and function in cancer patients.